LXRX (Lexicon Pharmaceuticals) FCF Yield %: -3.31 (As of Jun. 29, 2026)


LXRX Lexicon Pharmaceuticals Inc LXRX
57 GF Score
Price $2.64
GF Value $8.32
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Lexicon Pharmaceuticals FCF Yield %?

Lexicon Pharmaceuticals LXRX +3.94% 57 FCF Yield % is -3.31 as of Jun. 29, 2026. GuruFocus rates LXRX with a GF Score™ of 57/100 and a GF Value™ of $8.32 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,415 Biotechnology companies, Lexicon Pharmaceuticals ranks better than 68.9% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Lexicon Pharmaceuticals's Trailing 12-Month Free Cash Flow is $-38.80 Mil, and Market Cap is $1,172.68 Mil. Therefore, Lexicon Pharmaceuticals's FCF Yield % for today is -3.31%.

The historical rank and industry rank for Lexicon Pharmaceuticals's FCF Yield % or its related term are showing as below:

LXRX' s FCF Yield % Range Over the Past 10 Years
Min: -136.05   Med: -19.42   Max: 62.6
Current: -3.31


During the past 13 years, the highest FCF Yield % of Lexicon Pharmaceuticals was 62.60%. The lowest was -136.05%. And the median was -19.42%.

LXRX's FCF Yield % is ranked better than
68.9% of 1415 companies
in the Biotechnology industry
Industry Median: -9.62 vs LXRX: -3.31

Lexicon Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was -69.80%.


Lexicon Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Lexicon Pharmaceuticals FCF Yield % Related Terms


Lexicon Pharmaceuticals FCF Yield % Historical Data

* Premium members only.

The historical data trend for Lexicon Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexicon Pharmaceuticals FCF Yield % Chart

Lexicon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.04 -25.02 -43.33 -67.35 -16.23

Lexicon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -104.64 19.78 -19.43 -16.49 -8.91

LXRX vs CGEM, WVE, CRVS: FCF Yield % Comparison

For the Biotechnology subindustry, Lexicon Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexicon Pharmaceuticals FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lexicon Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Lexicon Pharmaceuticals's FCF Yield % falls into.


LXRX
57GF Score
Lexicon Pharmaceuticals Inc LXRX
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lexicon Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Lexicon Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-67.851 / 417.9859
=-16.23%

Lexicon Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-14.73 * 4 / 661.089
=-8.91%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -3.31 mean?
Lexicon Pharmaceuticals (LXRX) has a FCF Yield % of -3.31 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lexicon Pharmaceuticals and its competitors. According to the industry distribution chart, Lexicon Pharmaceuticals ranks #440 out of 1415 companies in the Biotechnology industry, placing it in the top 31.1%.
Is Lexicon Pharmaceuticals' FCF Yield % too high?
Lexicon Pharmaceuticals' current FCF Yield % is -3.31. Based on the distribution chart, Lexicon Pharmaceuticals ranks #440 out of 1415 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Lexicon Pharmaceuticals has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lexicon Pharmaceuticals' FCF Yield % compare to CGEM and WVE?
According to the Biotechnology industry distribution chart, Lexicon Pharmaceuticals ranks #440 out of 1415 companies for FCF Yield %. This puts Lexicon Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lexicon Pharmaceuticals and its competitors. Lexicon Pharmaceuticals's current FCF Yield % is -3.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lexicon Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lexicon Pharmaceuticals (LXRX) is currently considered Possible Value Trap. The stock's GF Value™ is $8.32, compared to a current price of $2.64 — trading 68.3% below its estimated fair value. The current FCF Yield % is -3.31. Lexicon Pharmaceuticals' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Lexicon Pharmaceuticals (LXRX), the current FCF Yield % is -3.31 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lexicon Pharmaceuticals (LXRX) Overvalued in 2026?

Based on GuruFocus' analysis, Lexicon Pharmaceuticals stock appears to be undervalued. The current stock price of $2.64 is trading 68.3% below its estimated GF Value™ of $8.32. GuruFocus considers Lexicon Pharmaceuticals to be Possible Value Trap.

Key valuation signals for LXRX:

  • FCF Yield %: -3.31
  • GF Value™: $8.32 vs. price of $2.64 (68.3% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the LXRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lexicon Pharmaceuticals Business Description

Address 2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
57GF Score

Get the complete analysis for LXRX

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.64
Price
$8.32
GF Value